Development of next-generation tumor-homing induced neural stem cells to enhance treatment of metastatic cancers.

Science Advances
Wulin JiangShawn D Hingtgen

Abstract

Engineered tumor-homing neural stem cells (NSCs) have shown promise in treating cancer. Recently, we transdifferentiated skin fibroblasts into human-induced NSCs (hiNSC) as personalized NSC drug carriers. Here, using a SOX2 and spheroidal culture-based reprogramming strategy, we generated a new hiNSC variant, hiNeuroS, that was genetically distinct from fibroblasts and first-generation hiNSCs and had significantly enhanced tumor-homing and antitumor properties. In vitro, hiNeuroSs demonstrated superior migration to human triple-negative breast cancer (TNBC) cells and in vivo rapidly homed to TNBC tumor foci following intracerebroventricular (ICV) infusion. In TNBC parenchymal metastasis models, ICV infusion of hiNeuroSs secreting the proapoptotic agent TRAIL (hiNeuroS-TRAIL) significantly reduced tumor burden and extended median survival. In models of TNBC leptomeningeal carcinomatosis, ICV dosing of hiNeuroS-TRAIL therapy significantly delayed the onset of tumor formation and extended survival when administered as a prophylactic treatment, as well as reduced tumor volume while prolonging survival when delivered as established tumor therapy.

References

Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Jul 27, 1999·Journal of Neuro-oncology·J C ReijneveldE E Voest
Aug 5, 2000·Neurosurgery·D I SandbergP H Gutin
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·K S AboodyE Y Snyder
Sep 4, 2003·Human Gene Therapy·Yi TangRalph Weissleder
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy U LinEric P Winer
Aug 4, 2006·Blood Reviews·Quentin A Hill, Roger G Owen
Nov 13, 2008·Journal of Cell Science·Laura KerosuoKirmo Wartiovaara
Jun 30, 2009·Pharmacotherapy·Aaron M CookJimmi Hatton
May 1, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H GauthierV Diéras
Jun 4, 2010·Stem Cell Reviews and Reports·Seung U Kim
Nov 16, 2011·Stem Cells·Donghong ZhaoKaren S Aboody
Mar 9, 2012·Biochemistry Research International·Mairim Alexandra SolisLynn L H Huang
Mar 30, 2012·Omics : a Journal of Integrative Biology·Guangchuang YuQing-Yu He
Oct 1, 2013·Trends in Molecular Medicine·Daniel W Stuckey, Khalid Shah
Nov 20, 2013·Progress in Neurobiology·Margherita RuggieriStefania Corti
Jan 15, 2014·Cellular and Molecular Neurobiology·Can ZhangZe-Jian Wang
Sep 1, 2015·Methods : a Companion to Methods in Enzymology·Juli Rodriguez BagóShawn D Hingtgen
Jan 20, 2016·Breast Cancer Research : BCR·Isabell WitzelHarriet Wikman
Feb 26, 2016·Journal of Neuro-oncology·Rezvan RostamiBahman Jabbari
Dec 29, 2016·The New England Journal of Medicine·Christine E BrownBehnam Badie
Jan 17, 2017·Pediatric Neurology·Jessica L Cohen-PfefferIrene Slavc
Feb 6, 2017·Science Translational Medicine·Juli R BagóShawn D Hingtgen
Sep 20, 2017·Seminars in Oncology·Ciara C O'SullivanSusan E Bates
Sep 25, 2017·Methods : a Companion to Methods in Enzymology·Ebrahim ShahbaziHossein Baharvand
Oct 27, 2017·Oncotarget·Gautam NayarPeter E Fecci
Jun 19, 2018·Annals of Translational Medicine·Evelyn M Brosnan, Carey K Anders
Jul 7, 2018·Therapeutic Advances in Medical Oncology·Nuria KoteckiAhmad Awada
Jul 18, 2018·Clinical Neurology and Neurosurgery·Hazem I AssiHaidar El Darsa
Aug 23, 2018·Stem Cells Translational Medicine·Rachael MooneyKaren S Aboody
Oct 17, 2018·Lung Cancer : Targets and Therapy·Farkhad ManapovChukwuka Eze
Mar 2, 2019·Critical Reviews in Oncology/hematology·Maria Alice Franzoi, Gabriel N Hortobagyi

❮ Previous
Next ❯

Software Mentioned

AMI
QuantStudio
Seurat
Monocle2
Aura
Fiji ImageJ
hiNeuroS
clusterProfiler

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.